Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome

NCT03679702 is registered in ClinicalTrials.gov with Michael Krychman, MD as lead sponsor.

NCT NCT03679702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03679702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome
Lead sponsor
Michael Krychman, MD
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2018
Completion date
December 1, 2019
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sexual dysfunction